Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0P9BG
|
||||
Former ID |
DNC013711
|
||||
Drug Name |
3-benzyloxy-4-methoxy-2'-hydroxychalcone
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529976] | ||
Structure |
Download2D MOL |
||||
Formula |
C23H20O4
|
||||
Canonical SMILES |
COC1=C(C=C(C=C1)C=CC(=O)C2=CC=CC=C2O)OCC3=CC=CC=C3
|
||||
InChI |
1S/C23H20O4/c1-26-22-14-12-17(11-13-21(25)19-9-5-6-10-20(19)24)15-23(22)27-16-18-7-3-2-4-8-18/h2-15,24H,16H2,1H3/b13-11+
|
||||
InChIKey |
QYADGBNDKLLFIV-ACCUITESSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Prostaglandin G/H synthase 2 | Target Info | Inhibitor | [529976] | |
KEGG Pathway | Arachidonic acid metabolism | ||||
Metabolic pathways | |||||
NF-kappa B signaling pathway | |||||
VEGF signaling pathway | |||||
TNF signaling pathway | |||||
Retrograde endocannabinoid signaling | |||||
Serotonergic synapse | |||||
Ovarian steroidogenesis | |||||
Oxytocin signaling pathway | |||||
Regulation of lipolysis in adipocytes | |||||
Leishmaniasis | |||||
Pathways in cancer | |||||
Chemical carcinogenesis | |||||
MicroRNAs in cancer | |||||
Small cell lung cancer | |||||
PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.